Patented RNAi Virucide ‘Tomovircona’ From Silicon Gene Technologies (Shanghai) Co., Ltd. Gains ISO Approval
On January 09, 2026, New common name provisionally approved for a RNAi virucide from Silicon Gene Technologies (Shanghai) Co., Ltd. Development code SG-001.
Tomovircona is an RNA-based virucide—specifically, a recombinant tobacco mosaic virus coat protein mRNA–targeting double-stranded interfering RNA—developed by Silicon Gene Technologies (Shanghai) Co., Ltd. Its development code is SG- 001.
- STATUS: ISO
- CAS NAME: RNA (recombinant tobacco mosaic virus coat protein mRNA-specific double-stranded interfering)
- CAS REG. NO.: 3052205-09-8
- ACTIVITY: Virucide (RNAi)
About Silicon Gene Technologies (Shanghai) Co., Ltd.
Silicon Gene Technologies (Shanghai) Co., Ltd. is a Shanghai-based biotechnology company focused on the development and commercialization of RNA-based agricultural and biological solutions. Founded with the mission of advancing environmentally sustainable pest and disease control technologies, the company specializes in RNA interference (RNAi) platforms and RNA nano-pesticides designed to precisely target harmful pests and pathogens while minimizing impact on non-target organisms and the environment.
Leveraging innovative synthetic biology and gene-targeting technologies, Silicon Gene Technologies develops products intended to offer green alternatives to traditional chemical pesticides, supporting global agricultural productivity and ecological health.
